Exergen Corporation: New Data Confirms No-Touch Thermometers Miss Five Out of Six Fevers


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Exergen Corporation: New Data Confirms No-Touch Thermometers Miss Five Out of Six Fevers
Non-contact thermometers are proven to be ineffective in measuring actual body temperature, while the accuracy of the TemporalScanner is supported by more than 80 peer-reviewed published clinical studies.

As COVID-19 continues to set new records nationwide, the importance of understanding the difference in accuracy between temporal artery thermometers (TAT) and non-contact devices – now used widely for public temperature screenings – is of paramount importance. Non-contact thermometers are proven to be ineffective in measuring actual body temperature, while the accuracy of the TemporalScanner is supported by more than 80 peer-reviewed published clinical studies. This has serious ramifications for family health and public safety.  

A new study in the American Journal of Infection Control is the first to compare the accuracy of no-touch thermometers to temporal artery thermometers. Australian researchers conducted a prospective observational study on a sample of 265 non-infectious patients at two hospitals.

When body temperatures read below 99.5 degrees Fahrenheit, the thermometers showed similar results, but as temperatures rose above that, non-contact scanners’ accuracy decreased. Temperatures were farther apart as they rose. The non-contact scanners missed five out of every six fevers detected by Exergen temporal artery thermometers.

According to the authors, “This is the first study to compare the accuracy of non-contact infrared thermometers (NCIT) to TAT in adult patients. Although mass fever screening is currently underway using NCIT, these results indicate that the NCIT may not be the most accurate device for fever mass screening during a pandemic.”

“During this escalating and unpredictable pandemic, there is one constant in helping to ensure public safety: the ability to accurately screen for fever,” said Francesco Pompei, Ph.D., CEO of Exergen Corporation. “Non-contact thermometers are proven to be inaccurate in measuring core body temperature, yet they’ve been used extensively from the start of the pandemic, giving a false sense of security. In public settings, they are large ‘theater,” and as such their use should be seriously questioned. Only thermometers with extensive clinical studies, such as the Exergen TemporalScanner, can be trusted for accuracy during these threatening times of COVID.”

ABOUT EXERGEN CORPORATION
Exergen manufactures and markets two series of the TemporalScanner thermometer: a professional version for hospitals and clinics, and a consumer version sold in major retailers nationwide. More than two billion temperatures are taken each year with TemporalScanners. Used in thousands of hospitals and clinics across the country as well as in millions of homes, TemporalScanners are the 1 preference of pediatricians, 1 preference of nurses, and 1 selling retail thermometer. The Exergen TemporalScanner's accuracy is supported by more than 80 peer-reviewed published clinical studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. 

Tags : #ExergenCorporation #Non-contactthermometers #thermometers #Covid19Infection #InfectionControl #publicsafety

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026